Share-based Payment Arrangement, Expense in USD of Vaxxinity, Inc. from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vaxxinity, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2020 to Q4 2023.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2023 was $1.08M, a 54.1% decline year-over-year.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2023 was $7.51M, a 13.8% decline year-over-year.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.51M, a 13.8% decline from 2022.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.71M, a 71.3% decline from 2021.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $30.4M, unchanged from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Vaxxinity, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $7.51M $1.08M -$1.27M -54.1% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2024
Q3 2023 $8.78M $1.77M -$588K -24.9% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $9.37M $2.43M +$607K +33.2% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $8.76M $2.23M +$47K +2.16% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $8.71M $2.35M -$22.4M -90.5% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $31.1M $2.36M +$893K +61% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $30.2M $1.83M +$1.02M +128% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $29.2M $2.18M -$1.26M -36.7% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $30.4M $24.7M 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023
Q3 2021 $1.46M $0 0% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $802K 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $3.44M 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q3 2020 $1.46M 01 Jul 2020 30 Sep 2020 10-Q 23 Dec 2021

Vaxxinity, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.51M -$1.21M -13.8% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2024
2022 $8.71M -$21.7M -71.3% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024
2021 $30.4M $0 0% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2020 $30.4M 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.